Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Issue of shares and TVR

September 13, 2021
RNS Number : 6078L Renalytix PLC 13 September 2021       Renalytix plc (" Renalytix " or the " Company ")     Issue of shares under the 2020 employee share purchase plan and Total Voting Rights   NEW YORK and SALT LAKE CITY , September 13 2021 - Renalytix Plc   (NASDAQ: RNLX) (LSE: RENX)  

Director/PDMR Shareholding

September 6, 2021
RNS Number : 8886K Renalytix PLC 06 September 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 6 September 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 3,000

Presentation at 2021 Wells Fargo Healthcare Conf.

September 3, 2021
RNS Number : 6161K Renalytix PLC 03 September 2021     Renalytix plc (" Renalytix " or the " Company ")     Renalytix to present at the 2021 Wells Fargo Virtual Healthcare Conference   NEW YORK and SALT LAKE CITY , September 3, 2021 -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces that the

Second Price Monitoring Extn

August 31, 2021
RNS Number : 2789K Renalytix PLC 31 August 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Price Monitoring Extension

August 31, 2021
RNS Number : 2775K Renalytix PLC 31 August 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered

Price Monitoring Extension

August 31, 2021
RNS Number : 2097K Renalytix PLC 31 August 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered

Appointment of Daniel J. Levangie to Board

August 31, 2021
RNS Number : 1082K Renalytix PLC 31 August 2021     Renalytix plc (" Renalytix " or the " Company ")     Renalytix Appoints Daniel J. Levangie to its Board of Directors   Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation

Peer reviewed publication

August 26, 2021
RNS Number : 8163J Renalytix PLC 26 August 2021   Renalytix plc (" Renalytix " or the " Company ")     Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX TM Testing at Primary Care Level   Peer reviewed publication in Journal of Medical Economics supports payer coverage for

Director/PDMR Shareholding

August 13, 2021
RNS Number : 6311I Renalytix PLC 13 August 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 13 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000

Director/PDMR Dealing

August 6, 2021
RNS Number : 9108H Renalytix PLC 06 August 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 6 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000
Displaying 51 - 60 of 209